المؤلفون: Shamsi, S., Nejad, H. Safaee, Salehi, R., Zareie, E., Hamedi, Sh., Mansouri, M.

المصدر: Hydrometallurgy ; volume 222, page 106185 ; ISSN 0304-386X

الاتاحة: http://dx.doi.org/10.1016/j.hydromet.2023.106185
https://api.elsevier.com/content/article/PII:S0304386X23001676?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0304386X23001676?httpAccept=text/plain

المؤلفون: Ansari, M, Mosalaei, A, Ahmadloo, N, Rasekhi, A, Geramizadeh, B, Razmkon, A, Anvari, K, Afarid, M, Dadras, A, Nafarieh, L, Mohammadianpanah, M, Nasrolahi, H, Hamedi, SH, Omidvari, S, Nami, M

المصدر: GMS German Medical Science; VOL: 15; DOC05 /20170228/

مصطلحات موضوعية: neuro-oncology, interdisciplinary, high-grade glioma, position statement, Shiraz, Neuroonkologie, interdisziplinär, hochgradiges Gliom, Positionspapier, ddc: 610

Relation: Akbari H, Macyszyn L, Da X, Bilello M, Wolf RL, Martinez-Lage M, Biros G, Alonso-Basanta M, O'Rourke DM, Davatzikos C. Imaging Surrogates of Infiltration Obtained Via Multiparametric Imaging Pattern Analysis Predict Subsequent Location of Recurrence of Glioblastoma. Neurosurgery. 2016 Apr;78(4):572-80. DOI:10.1227/NEU.0000000000001202; Alcedo-Guardia R, Labat E, Blas-Boria D, Vivas-Mejia PE. Diagnosis and New Treatment Modalities for Glioblastoma: Do They Improve Patient Survival? Curr Mol Med. 2016 Apr 29. DOI:10.2174/1566524016666160429120150; Amouheidari A, Hemati S, Sabouri M, Emami J, Mehrzad V, Hekmatnia H, et al. The Nexus between Interdisciplinary Approach and Extended Survival in CNS Tumors, Neuro-Oncology Scientific Club (NOSC) Meeting Report, 27 December 2012, Isfahan, Iran. Res Cancer Tumor. 2013;2(1):1-9. DOI:10.5923/j.rct.20130201.01; Ansari M, Nasrolahi H, Kani AA, Mohammadianpanah M, Ahmadloo N, Omidvari S, Mosalaei A. Pediatric glioblastoma multiforme: A single-institution experience. Indian J Med Paediatr Oncol. 2012 Jul;33(3):155-60. DOI:10.4103/0971-5851.103142; Ansari M, Mosalaei A, Ahmadloo N, Rasekhi A, Geramizadeh B, Razmkon A, Afarid M, Dadras A, Nafarieh L, Mohammadianpanah M, Nasrolahi H, Hamedi SH, Omidvari S, Nami M. A connect-approach in high-grade glioma management; Position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran. PeerJ Preprints. 2016;4:e2575v1. DOI:10.7287/peerj.preprints.2575v1; Anvari K, Bahadorkhan G, Nekooi S, Taghizadeh A, Kheradmand H, Nowferesti G, et al. Towards the Real Interdisciplinary Approach in Treating Brain Tumors: Report from the Neuro-Oncology Scientific Club opening meeting - NOSC 2011-13 October- Mashhad, IR Iran. Webmedcentral. 2011;2(10):WMC002381. DOI:10.9754/journal.wmc.2011.002381; Anvari K, Bahadorkhan G, Silanian-Toussi M, Rahighi S, Ghavamnasiri M, Saeedi M, et al. From fundamental brain tumor science to interdisciplinary bedside care; the outcome report from the Neuro-Oncology Scientific Club second meet-up (NOSC-2), 19th April 2012, Mashhad, Iran. Int J Med Clin Res. 2012;3(5):168-75. DOI:10.9735/0976-5530.3.5.168-175; Anvari K, Bahadorkhan G, Etemad-Rezaie H, Silanian-Toussi M, Nekooei S, Samini F, et al. Prognostic Factors and Treatment Outcome in Glial Brain Tumors; Data from the Third Neuro-oncology Scientific Club's Input Forum, 2013, Mashhad. Iran. Br J Med Med Res. 2014;4(18):3538-53. DOI:10.9734/BJMMR/2014/9142; Anvari K, Hosseini S, Rahighi S, Toussi MS, Roshani N, Torabi-Nami M. Intracranial meningiomas: Prognostic factors and treatment outcome in patients undergoing postoperative radiation therapy. Adv Biomed Res. 2016;5:83. DOI:10.4103/2277-9175.182214; Anvari K, Ersi MF, Etemad-Rezaie H, Nekooie S, Arbabi F, Ganjeifar B, et al. P21.04 Clinical pathway in glioma management; from NOSC (Neuro-Oncology Scientific Club) meetings to bedside practice. Neuro Oncol. 2016;18(suppl 4):iv81-iv2. DOI:10.1093/neuonc/now188.292; Ashjazadeh N, Boostani R, Ekhtiari H, Emamghoreishi M, Farrokhi M, Ghanizadeh A, Hatam G, Hadianfard H, Lotfi M, Mortazavi SM, Mousavi M, Montakhab A, Nili M, Razmkon A, Salehi S, Sodagar AM, Setoodeh P, Taghipour M, Torabi-Nami M, Vesal A. Operationalizing Cognitive Science and Technologies' Research and Development; the "Brain and Cognition Study Group (BCSG)" Initiative from Shiraz, Iran. Basic Clin Neurosci. 2014;5(2):104-16.; Badhiwala JH, Nassiri F, Almenawer SA. GBM surgery in the elderly-time to be more aggressive? Clin Neurol Neurosurg. 2016 Feb;141:131-2. DOI:10.1016/j.clineuro.2015.10.009; Bagheri MH, Ahmadloo N, Rezaian S. Artifacts in magnetic resonance imaging after surgical resection of brain tumors. Magn Reson Imaging. 2013 Jun;31(5):700-2. DOI:10.1016/j.mri.2012.11.001; Baldi I, Huchet A, Bauchet L, Loiseau H. Épidémiologie des glioblastomes [Epidemiology of glioblastoma]. Neurochirurgie. 2010 Dec;56(6):433-40. DOI:10.1016/j.neuchi.2010.07.011; Burton E, Ugiliweneza B, Woo S, Skirboll S, Boaky M. A Surveillance, Epidemiology and End Results-Medicare data analysis of elderly patients with glioblastoma multiforme: Treatment patterns, outcomes and cost. Mol Clin Oncol. 2015 Sep;3(5):971-978. DOI:10.3892/mco.2015.590; Carlberg M, Hardell L. Decreased survival of glioma patients with astrocytoma grade IV (glioblastoma multiforme) associated with long-term use of mobile and cordless phones. Int J Environ Res Public Health. 2014 Oct;11(10):10790-805. DOI:10.3390/ijerph111010790; Chinot OL, Nishikawa R, Mason W, Henriksson R, Saran F, Cloughesy T, Garcia J, Revil C, Abrey L, Wick W. Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio. Neuro Oncol. 2016 Sep;18(9):1313-8. DOI:10.1093/neuonc/now046; Darefsky AS, King JT Jr, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries. Cancer. 2012 Apr;118(8):2163-72. DOI:10.1002/cncr.26494; Evans MR, Evans SB. Glioblastoma multiforme: a devastating diagnosis. Pract Neurol. 2016 Oct;16(5):416-8. DOI:10.1136/practneurol-2016-001424; Faranoush M, Torabi-Nami M, Mehrvar A, Hedayati-Asl A, Tashvighi M, Parsa R, et al. Classifying Pediatric Central Nervous System Tumors through near Optimal Feature Selection and Mutual Information: A Single Center Cohort. Middle East J Cancer. 2013;4(4):153-62.; Franceschi S, Lessi F, Aretini P, Mazzanti CM, Menicagli M, La Ferla M, De Gregorio V, Caramella D, Naccarato AG, Bevilacqua G, Bonadio AG, Pasqualetti F. Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing. Neuro Oncol. 2016 Feb;18(2):298-300. DOI:10.1093/neuonc/nov314; Haddad P, Zali A, Tabatabaeefar M, Nikoofar A, Hadizadeh Kharazi H, Ghadyani M, et al. Turning Interdisciplinary Brain Tumor Science into Survival; Report from the NeuroOncology Scientific Club Opening Session, NOSC 2012 -19 January- Tehran, IR Iran. Rep Opinion. 2012;4(2):42-53. DOI:10.7537/marsroj040212.07; Haddad P, Shazadi S, Samiei F, Kharrazi HH, Tabatabaeefar M, Rakhsha A, Faranoosh M, Torabi-Nami M, Dadras A, Liaghi A, Nafarieh L. An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative. Int J Clin Exp Med. 2015;8(3):3946-55.; Huang RY, Rahman R, Ballman KV, Felten SJ, Anderson SK, Ellingson BM, Nayak L, Lee EQ, Abrey LE, Galanis E, Reardon DA, Pope WB, Cloughesy TF, Wen PY. The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab. Clin Cancer Res. 2016 Feb;22(3):575-81. DOI:10.1158/1078-0432.CCR-14-3040; Hutterer M, Nowosielski M, Putzer D, Jansen NL, Seiz M, Schocke M, McCoy M, Göbel G, la Fougère C, Virgolini IJ, Trinka E, Jacobs AH, Stockhammer G. [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. Neuro Oncol. 2013 Mar;15(3):341-51. DOI:10.1093/neuonc/nos300; Janinis J, Efstathiou E, Panopoulos C, Samantas E, Aravantinos G, Christodoulou C, Skarlos D. Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status. Med Oncol. 2000 May;17(2):106-10. DOI:10.1007/BF02796204; Jaspan T, Morgan PS, Warmuth-Metz M, Sanchez Aliaga E, Warren D, Calmon R, Grill J, Hargrave D, Garcia J, Zahlmann G. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas. AJNR Am J Neuroradiol. 2016 Sep;37(9):1581-7. DOI:10.3174/ajnr.A4782; Jones LW, Cohen RR, Mabe SK, West MJ, Desjardins A, Vredenburgh JJ, Friedman AH, Reardon DA, Waner E, Friedman HS. Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing. J Neurooncol. 2009 Aug;94(1):79-85. DOI:10.1007/s11060-009-9803-x; Kim ES, Satter M, Reed M, Fadell R, Kardan A. A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma. Neuroradiol J. 2016 Jun;29(3):193-7. DOI:10.1177/1971400916639962; Kong BH, Moon JH, Huh YM, Shim JK, Lee JH, Kim EH, Chang JH, Kim DS, Hong YK, Kim SH, Lee SJ, Kang SG. Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients. Stem Cells Int. 2014;2014:838950. DOI:10.1155/2014/838950; Krivosheya D, Prabhu SS, Weinberg JS, Sawaya R. Technical principles in glioma surgery and preoperative considerations. J Neurooncol. 2016 Nov;130(2):243-252. DOI:10.1007/s11060-016-2171-4; Lamano JB, Ampie L, Choy W, Kesavabhotla K, DiDomenico JD, Oyon DE, Parsa AT, Bloch O. Immunomonitoring in glioma immunotherapy: current status and future perspectives. J Neurooncol. 2016 Mar;127(1):1-13. DOI:10.1007/s11060-015-2018-4; Lohkamp LN, Schinz M, Gehlhaar C, Guse K, Thomale UW, Vajkoczy P, Heppner FL, Koch A. MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma. PLoS ONE. 2016;11(6):e0156422. DOI:10.1371/journal.pone.0156422; Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun;131(6):803-20. DOI:10.1007/s00401-016-1545-1; Paldor I, Drummond KJ, Kaye AH. IDH1 mutation may not be prognostically favorable in glioblastoma when controlled for tumor location: A case-control study. J Clin Neurosci. 2016 Dec;34:117-120. DOI:10.1016/j.jocn.2016.05.016; Pessina F, Navarria P, Cozzi L, Ascolese AM, Simonelli M, Santoro A, Tomatis S, Riva M, Fava E, Scorsetti M, Bello L. Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy. Ann Surg Oncol. 2016 Sep;23(9):3040-6. DOI:10.1245/s10434-016-5222-3; Platten M, Bunse L, Wick W, Bunse T. Concepts in glioma immunotherapy. Cancer Immunol Immunother. 2016 Oct;65(10):1269-75. DOI:10.1007/s00262-016-1874-x; Sandmann T, Bourgon R, Garcia J, Li C, Cloughesy T, Chinot OL, Wick W, Nishikawa R, Mason W, Henriksson R, Saran F, Lai A, Moore N, Kharbanda S, Peale F, Hegde P, Abrey LE, Phillips HS, Bais C. Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial. J Clin Oncol. 2015 Sep;33(25):2735-44. DOI:10.1200/JCO.2015.61.5005; Sarmiento JM, Mukherjee D, Black KL, Fan X, Hu JL, Nuno MA, Patil CG. Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations? J Neurol Surg A Cent Eur Neurosurg. 2016 May;77(3):195-200. DOI:10.1055/s-0035-1566121; Satoer D, Visch-Brink E, Dirven C, Vincent A. Glioma surgery in eloquent areas: can we preserve cognition? Acta Neurochir (Wien). 2016 Jan;158(1):35-50. DOI:10.1007/s00701-015-2601-7; Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G; ESMO Guidelines Working Group. High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014 Sep;25 Suppl 3:iii93-101. DOI:10.1093/annonc/mdu050; Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009 May;10(5):459-66. DOI:10.1016/S1470-2045(09)70025-7; Stupp R, Tonn JC, Brada M, Pentheroudakis G; ESMO Guidelines Working Group. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May;21 Suppl 5:v190-3. DOI:10.1093/annonc/mdq187; Sun GC, Wang F, Chen XL, Yu XG, Ma XD, Zhou DB, Zhu RY, Xu BN. Impact of Virtual and Augmented Reality Based on Intraoperative Magnetic Resonance Imaging and Functional Neuronavigation in Glioma Surgery Involving Eloquent Areas. World Neurosurg. 2016 Dec;96:375-382. DOI:10.1016/j.wneu.2016.07.107; Torabi-Nami M, Hejazi Farahmand S, Mohammadzadeh F. Neuro-oncology scientific club and the national Iranian brain tumor registry. Neuro Oncol. 2012 Sep;14 Suppl 3:P.282. DOI:10.1093/neuonc/nos183; Tuovinen N, de Pasquale F, Caulo M, Caravasso CF, Giudice E, Miceli R, Ingrosso G, Laprie A, Santoni R, Sabatini U. Transient effects of tumor location on the functional architecture at rest in glioblastoma patients: three longitudinal case studies. Radiat Oncol. 2016 Aug;11(1):107. DOI:10.1186/s13014-016-0683-x; Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, Cohen-Jonathan-Moyal E, Frappaz D, Henriksson R, Balana C, Chinot O, Ram Z, Reifenberger G, Soffietti R, Wick W; European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol. 2014 Aug;15(9):e395-403. DOI:10.1016/S1470-2045(14)70011-7; http://dx.doi.org/10.3205/000246; http://nbn-resolving.de/urn:nbn:de:0183-0002463; http://www.egms.de/en/journals/gms/2017-15/000246.shtml

الاتاحة: https://doi.org/10.3205/000246
http://nbn-resolving.de/urn:nbn:de:0183-0002463
http://www.egms.de/en/journals/gms/2017-15/000246.shtml

المؤلفون: Hamedi, Sh, Afsahi, M.M., Nematollahi, M.H., Akhavan, H.R.

المساهمون: Iran National Science Foundation

المصدر: LWT ; volume 146, page 111448 ; ISSN 0023-6438

الاتاحة: http://dx.doi.org/10.1016/j.lwt.2021.111448
https://api.elsevier.com/content/article/PII:S0023643821006010?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0023643821006010?httpAccept=text/plain

Additional Titles: Ein umfassender Ansatz zur Behandlung hochgradiger Gliome: Positionspapier des Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran

المؤلفون: Ansari, M, Mosalaei, A, Ahmadloo, N, Rasekhi, A, Geramizadeh, B, Razmkon, A, Anvari, K, Afarid, M, Dadras, A, Nafarieh, L, Mohammadianpanah, M, Nasrolahi, H, Hamedi, SH, Omidvari, S, Nami, M

المصدر: GMS German Medical Science; VOL: 15; DOC05 /20170228/

مصطلحات الفهرس: neuro-oncology, interdisciplinary, high-grade glioma, position statement, Shiraz, Neuroonkologie, interdisziplinär, hochgradiges Gliom, Positionspapier, ddc: 610, article

URL: http://nbn-resolving.de/urn:nbn:de:0183-0002463
http://www.egms.de/en/journals/gms/2017-15/000246.shtml
Akbari H, Macyszyn L, Da X, Bilello M, Wolf RL, Martinez-Lage M, Biros G, Alonso-Basanta M, O'Rourke DM, Davatzikos C. Imaging Surrogates of Infiltration Obtained Via Multiparametric Imaging Pattern Analysis Predict Subsequent Location of Recurrence of Glioblastoma. Neurosurgery. 2016 Apr;78(4):572-80. DOI: 10.1227/NEU.0000000000001202
Alcedo-Guardia R, Labat E, Blas-Boria D, Vivas-Mejia PE. Diagnosis and New Treatment Modalities for Glioblastoma: Do They Improve Patient Survival? Curr Mol Med. 2016 Apr 29. DOI: 10.2174/1566524016666160429120150
Amouheidari A, Hemati S, Sabouri M, Emami J, Mehrzad V, Hekmatnia H, et al. The Nexus between Interdisciplinary Approach and Extended Survival in CNS Tumors, Neuro-Oncology Scientific Club (NOSC) Meeting Report, 27 December 2012, Isfahan, Iran. Res Cancer Tumor. 2013;2(1):1-9. DOI: 10.5923/j.rct.20130201.01
Ansari M, Nasrolahi H, Kani AA, Mohammadianpanah M, Ahmadloo N, Omidvari S, Mosalaei A. Pediatric glioblastoma multiforme: A single-institution experience. Indian J Med Paediatr Oncol. 2012 Jul;33(3):155-60. DOI: 10.4103/0971-5851.103142
Ansari M, Mosalaei A, Ahmadloo N, Rasekhi A, Geramizadeh B, Razmkon A, Afarid M, Dadras A, Nafarieh L, Mohammadianpanah M, Nasrolahi H, Hamedi SH, Omidvari S, Nami M. A connect-approach in high-grade glioma management; Position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran. PeerJ Preprints. 2016;4:e2575v1. DOI: 10.7287/peerj.preprints.2575v1
Anvari K, Bahadorkhan G, Nekooi S, Taghizadeh A, Kheradmand H, Nowferesti G, et al. Towards the Real Interdisciplinary Approach in Treating Brain Tumors: Report from the Neuro-Oncology Scientific Club opening meeting - NOSC 2011-13 October- Mashhad, IR Iran. Webmedcentral. 2011;2(10):WMC002381. DOI: 10.9754/journal.wmc.2011.002381
Anvari K, Bahadorkhan G, Silanian-Toussi M, Rahighi S, Ghavamnasiri M, Saeedi M, et al. From fundamental brain tumor science to interdisciplinary bedside care; the outcome report from the Neuro-Oncology Scientific Club second meet-up (NOSC-2), 19th April 2012, Mashhad, Iran. Int J Med Clin Res. 2012;3(5):168-75. DOI: 10.9735/0976-5530.3.5.168-175
Anvari K, Bahadorkhan G, Etemad-Rezaie H, Silanian-Toussi M, Nekooei S, Samini F, et al. Prognostic Factors and Treatment Outcome in Glial Brain Tumors; Data from the Third Neuro-oncology Scientific Club's Input Forum, 2013, Mashhad. Iran. Br J Med Med Res. 2014;4(18):3538-53. DOI: 10.9734/BJMMR/2014/9142
Anvari K, Hosseini S, Rahighi S, Toussi MS, Roshani N, Torabi-Nami M. Intracranial meningiomas: Prognostic factors and treatment outcome in patients undergoing postoperative radiation therapy. Adv Biomed Res. 2016;5:83. DOI: 10.4103/2277-9175.182214
Anvari K, Ersi MF, Etemad-Rezaie H, Nekooie S, Arbabi F, Ganjeifar B, et al. P21.04 Clinical pathway in glioma management; from NOSC (Neuro-Oncology Scientific Club) meetings to bedside practice. Neuro Oncol. 2016;18(suppl 4):iv81-iv2. DOI: 10.1093/neuonc/now188.292
Ashjazadeh N, Boostani R, Ekhtiari H, Emamghoreishi M, Farrokhi M, Ghanizadeh A, Hatam G, Hadianfard H, Lotfi M, Mortazavi SM, Mousavi M, Montakhab A, Nili M, Razmkon A, Salehi S, Sodagar AM, Setoodeh P, Taghipour M, Torabi-Nami M, Vesal A. Operationalizing Cognitive Science and Technologies' Research and Development; the "Brain and Cognition Study Group (BCSG)" Initiative from Shiraz, Iran. Basic Clin Neurosci. 2014;5(2):104-16.
Badhiwala JH, Nassiri F, Almenawer SA. GBM surgery in the elderly-time to be more aggressive? Clin Neurol Neurosurg. 2016 Feb;141:131-2. DOI: 10.1016/j.clineuro.2015.10.009
Bagheri MH, Ahmadloo N, Rezaian S. Artifacts in magnetic resonance imaging after surgical resection of brain tumors. Magn Reson Imaging. 2013 Jun;31(5):700-2. DOI: 10.1016/j.mri.2012.11.001
Baldi I, Huchet A, Bauchet L, Loiseau H. Épidémiologie des glioblastomes [Epidemiology of glioblastoma]. Neurochirurgie. 2010 Dec;56(6):433-40. DOI: 10.1016/j.neuchi.2010.07.011
Burton E, Ugiliweneza B, Woo S, Skirboll S, Boaky M. A Surveillance, Epidemiology and End Results-Medicare data analysis of elderly patients with glioblastoma multiforme: Treatment patterns, outcomes and cost. Mol Clin Oncol. 2015 Sep;3(5):971-978. DOI: 10.3892/mco.2015.590
Carlberg M, Hardell L. Decreased survival of glioma patients with astrocytoma grade IV (glioblastoma multiforme) associated with long-term use of mobile and cordless phones. Int J Environ Res Public Health. 2014 Oct;11(10):10790-805. DOI: 10.3390/ijerph111010790
Chinot OL, Nishikawa R, Mason W, Henriksson R, Saran F, Cloughesy T, Garcia J, Revil C, Abrey L, Wick W. Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio. Neuro Oncol. 2016 Sep;18(9):1313-8. DOI: 10.1093/neuonc/now046
Darefsky AS, King JT Jr, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries. Cancer. 2012 Apr;118(8):2163-72. DOI: 10.1002/cncr.26494
Evans MR, Evans SB. Glioblastoma multiforme: a devastating diagnosis. Pract Neurol. 2016 Oct;16(5):416-8. DOI: 10.1136/practneurol-2016-001424
Faranoush M, Torabi-Nami M, Mehrvar A, Hedayati-Asl A, Tashvighi M, Parsa R, et al. Classifying Pediatric Central Nervous System Tumors through near Optimal Feature Selection and Mutual Information: A Single Center Cohort. Middle East J Cancer. 2013;4(4):153-62.
Franceschi S, Lessi F, Aretini P, Mazzanti CM, Menicagli M, La Ferla M, De Gregorio V, Caramella D, Naccarato AG, Bevilacqua G, Bonadio AG, Pasqualetti F. Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing. Neuro Oncol. 2016 Feb;18(2):298-300. DOI: 10.1093/neuonc/nov314
Haddad P, Zali A, Tabatabaeefar M, Nikoofar A, Hadizadeh Kharazi H, Ghadyani M, et al. Turning Interdisciplinary Brain Tumor Science into Survival; Report from the NeuroOncology Scientific Club Opening Session, NOSC 2012 -19 January- Tehran, IR Iran. Rep Opinion. 2012;4(2):42-53. DOI: 10.7537/marsroj040212.07
Haddad P, Shazadi S, Samiei F, Kharrazi HH, Tabatabaeefar M, Rakhsha A, Faranoosh M, Torabi-Nami M, Dadras A, Liaghi A, Nafarieh L. An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative. Int J Clin Exp Med. 2015;8(3):3946-55.
Huang RY, Rahman R, Ballman KV, Felten SJ, Anderson SK, Ellingson BM, Nayak L, Lee EQ, Abrey LE, Galanis E, Reardon DA, Pope WB, Cloughesy TF, Wen PY. The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab. Clin Cancer Res. 2016 Feb;22(3):575-81. DOI: 10.1158/1078-0432.CCR-14-3040
Hutterer M, Nowosielski M, Putzer D, Jansen NL, Seiz M, Schocke M, McCoy M, Göbel G, la Fougère C, Virgolini IJ, Trinka E, Jacobs AH, Stockhammer G. [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. Neuro Oncol. 2013 Mar;15(3):341-51. DOI: 10.1093/neuonc/nos300
Janinis J, Efstathiou E, Panopoulos C, Samantas E, Aravantinos G, Christodoulou C, Skarlos D. Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status. Med Oncol. 2000 May;17(2):106-10. DOI: 10.1007/BF02796204
Jaspan T, Morgan PS, Warmuth-Metz M, Sanchez Aliaga E, Warren D, Calmon R, Grill J, Hargrave D, Garcia J, Zahlmann G. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas. AJNR Am J Neuroradiol. 2016 Sep;37(9):1581-7. DOI: 10.3174/ajnr.A4782
Jones LW, Cohen RR, Mabe SK, West MJ, Desjardins A, Vredenburgh JJ, Friedman AH, Reardon DA, Waner E, Friedman HS. Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing. J Neurooncol. 2009 Aug;94(1):79-85. DOI: 10.1007/s11060-009-9803-x
Kim ES, Satter M, Reed M, Fadell R, Kardan A. A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma. Neuroradiol J. 2016 Jun;29(3):193-7. DOI: 10.1177/1971400916639962
Kong BH, Moon JH, Huh YM, Shim JK, Lee JH, Kim EH, Chang JH, Kim DS, Hong YK, Kim SH, Lee SJ, Kang SG. Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients. Stem Cells Int. 2014;2014:838950. DOI: 10.1155/2014/838950
Krivosheya D, Prabhu SS, Weinberg JS, Sawaya R. Technical principles in glioma surgery and preoperative considerations. J Neurooncol. 2016 Nov;130(2):243-252. DOI: 10.1007/s11060-016-2171-4
Lamano JB, Ampie L, Choy W, Kesavabhotla K, DiDomenico JD, Oyon DE, Parsa AT, Bloch O. Immunomonitoring in glioma immunotherapy: current status and future perspectives. J Neurooncol. 2016 Mar;127(1):1-13. DOI: 10.1007/s11060-015-2018-4
Lohkamp LN, Schinz M, Gehlhaar C, Guse K, Thomale UW, Vajkoczy P, Heppner FL, Koch A. MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma. PLoS ONE. 2016;11(6):e0156422. DOI: 10.1371/journal.pone.0156422
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun;131(6):803-20. DOI: 10.1007/s00401-016-1545-1
Paldor I, Drummond KJ, Kaye AH. IDH1 mutation may not be prognostically favorable in glioblastoma when controlled for tumor location: A case-control study. J Clin Neurosci. 2016 Dec;34:117-120. DOI: 10.1016/j.jocn.2016.05.016
Pessina F, Navarria P, Cozzi L, Ascolese AM, Simonelli M, Santoro A, Tomatis S, Riva M, Fava E, Scorsetti M, Bello L. Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy. Ann Surg Oncol. 2016 Sep;23(9):3040-6. DOI: 10.1245/s10434-016-5222-3
Platten M, Bunse L, Wick W, Bunse T. Concepts in glioma immunotherapy. Cancer Immunol Immunother. 2016 Oct;65(10):1269-75. DOI: 10.1007/s00262-016-1874-x
Sandmann T, Bourgon R, Garcia J, Li C, Cloughesy T, Chinot OL, Wick W, Nishikawa R, Mason W, Henriksson R, Saran F, Lai A, Moore N, Kharbanda S, Peale F, Hegde P, Abrey LE, Phillips HS, Bais C. Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial. J Clin Oncol. 2015 Sep;33(25):2735-44. DOI: 10.1200/JCO.2015.61.5005
Sarmiento JM, Mukherjee D, Black KL, Fan X, Hu JL, Nuno MA, Patil CG. Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations? J Neurol Surg A Cent Eur Neurosurg. 2016 May;77(3):195-200. DOI: 10.1055/s-0035-1566121
Satoer D, Visch-Brink E, Dirven C, Vincent A. Glioma surgery in eloquent areas: can we preserve cognition? Acta Neurochir (Wien). 2016 Jan;158(1):35-50. DOI: 10.1007/s00701-015-2601-7
Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G; ESMO Guidelines Working Group. High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014 Sep;25 Suppl 3:iii93-101. DOI: 10.1093/annonc/mdu050
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009 May;10(5):459-66. DOI: 10.1016/S1470-2045(09)70025-7
Stupp R, Tonn JC, Brada M, Pentheroudakis G; ESMO Guidelines Working Group. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May;21 Suppl 5:v190-3. DOI: 10.1093/annonc/mdq187
Sun GC, Wang F, Chen XL, Yu XG, Ma XD, Zhou DB, Zhu RY, Xu BN. Impact of Virtual and Augmented Reality Based on Intraoperative Magnetic Resonance Imaging and Functional Neuronavigation in Glioma Surgery Involving Eloquent Areas. World Neurosurg. 2016 Dec;96:375-382. DOI: 10.1016/j.wneu.2016.07.107
Torabi-Nami M, Hejazi Farahmand S, Mohammadzadeh F. Neuro-oncology scientific club and the national Iranian brain tumor registry. Neuro Oncol. 2012 Sep;14 Suppl 3:P.282. DOI: 10.1093/neuonc/nos183
Tuovinen N, de Pasquale F, Caulo M, Caravasso CF, Giudice E, Miceli R, Ingrosso G, Laprie A, Santoni R, Sabatini U. Transient effects of tumor location on the functional architecture at rest in glioblastoma patients: three longitudinal case studies. Radiat Oncol. 2016 Aug;11(1):107. DOI: 10.1186/s13014-016-0683-x
Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, Cohen-Jonathan-Moyal E, Frappaz D, Henriksson R, Balana C, Chinot O, Ram Z, Reifenberger G, Soffietti R, Wick W; European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol. 2014 Aug;15(9):e395-403. DOI: 10.1016/S1470-2045(14)70011-7

المؤلفون: Omidvari, S, Zohourinia, S, Ansari, M, Ghahramani, L, Zare-Bandamiri, M, Mosalaei, A, Ahmadloo, N, Pourahmad, S, Nasrolahi, H, Hamedi, SH, Mohammadianpanah, M

مصطلحات موضوعية: RC0254 Neoplasms. Tumors. Oncology (including Cancer)

وصف الملف: text

Relation: http://eprints.kmu.ac.ir/22704/1/article%201.docx; Omidvari, S and Zohourinia, S and Ansari, M and Ghahramani, L and Zare-Bandamiri, M and Mosalaei, A and Ahmadloo, N and Pourahmad, S and Nasrolahi, H and Hamedi, SH and Mohammadianpanah, M (2015) Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial. Ann Coloproctol, 31 (4). pp. 123-30.

الاتاحة: http://eprints.kmu.ac.ir/22704/
http://eprints.kmu.ac.ir/22704/1/article%201.docx

المؤلفون: Jokar A, Abbasian A, Hamedi Sh

المصدر: Journal of Gastrointestinal & Digestive System.

مصطلحات موضوعية: medicine.medical_specialty, Constipation, Traditional medicine, business.industry, Symptomatic treatment, Alternative medicine, Disease, Omics, Iranian traditional medicine, medicine, Etiology, Effective treatment, medicine.symptom, business, Intensive care medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5ee914ba35fbac3d3c3b592b3e662304
https://doi.org/10.4172/2161-069x.s8-005